Sovaldi — Medica
genotype 2 or 3 chronic hepatitis C virus (HCV) in pediatric patients ≥3 years and <18 years (new start)
Preferred products
- Epclusa (brand)
Initial criteria
- Genotype 2 or 3 chronic HCV pediatric patients ≥3 and <18 years (new start): Sovaldi is not approved. Offer to review for Epclusa (brand only) using the standard Hepatitis C – Epclusa PA Policy criteria.
- Patient continuing therapy with Sovaldi: follow the standard Hepatitis C – Sovaldi PA Policy criteria.
Approval duration
as specified in the respective Hepatitis C policies